JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG AND CHANGE OF ADDRESS OF HONG KONG H SHARE REGISTRAR AND TRANSFER OFFICE

CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG AND CHANGE OF ADDRESS OF HONG KONG H SHARE REGISTRAR AND TRANSFER OFFICE

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2022

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2022

Final dividend in cash for the year ended December 31, 2021

Final dividend in cash for the year ended December 31, 2021

PARTIAL REPURCHASE AND CANCELLATION OF THE RESTRICTED A SHARES

PARTIAL REPURCHASE AND CANCELLATION OF THE RESTRICTED A SHARES

ANNOUNCEMENT ON ESTIMATED GROWTH IN RESULTS FOR THE HALF YEAR OF 2022

ANNOUNCEMENT ON ESTIMATED GROWTH IN RESULTS FOR THE HALF YEAR OF 2022

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2022

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2022

Final dividend in cash for the year ended December 31, 2021

Final dividend in cash for the year ended December 31, 2021

Final dividend in cash for the year ended December 31, 2021

Final dividend in cash for the year ended December 31, 2021

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top